Prince Pharmaceutical Co., Ltd. (6935) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Prince Pharmaceutical Co., Ltd. (6935:TWSE), powered by AI.

Current Price
$29.65
Sector
Healthcare
What is the Prince Pharmaceutical Co., Ltd. stock price forecast?

Prince Pharmaceutical Co., Ltd. is currently trading at $29.65. View real-time AI analysis on Alpha Lenz.

What is Prince Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Prince Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Prince Pharmaceutical Co., Ltd.'s P/E ratio?

View Prince Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.

Prince Pharmaceutical Co., Ltd.

TWSE · 6935
NT$29.65+0.10(+0.34%)
Ask about Prince Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Prince Pharmaceutical Co., Ltd.'s ROE is 12.3%. Explore profitability and growth together.

Ask for details

Company Overview

Prince Pharmaceutical Co., Ltd. is a healthcare company specializing in the manufacture and sale of active pharmaceutical ingredients, with a notable focus on vitamin B1 products. Established in 1962 and headquartered in Yunlin County, Taiwan, the company has expanded its reach to multiple international markets, including Japan, Korea, Spain, and several European countries. Beyond pharmaceutical ingredients, Prince Pharmaceutical Co., Ltd. offers a portfolio of health food items such as vitamin C and B complex tablets, plant extract capsules, natto and rhodiola extract capsules, and probiotic sachets. The business operates across key segments including health foods and Western medicine, with health food products representing a steadily growing share of its revenues. As a supplier to both domestic and overseas clients, the company plays a vital role in the broader pharmaceutical and specialty drug sector, supporting healthcare distribution and manufacturing chains in Asia and beyond.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees210

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.06BRevenue
0.00Shares Out
210Employees

Margins

21.07%Gross
16.66%EBITDA
10.50%Operating
9.92%Pre-Tax
9.12%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

14.02%Rev 3Yr
28.99%Rev 5Yr
17.79%Op Inc 3Yr
N/AOp Inc 5Yr
23.16%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

6.76%ROA
12.34%ROE
8.02%ROIC

Financial Health

NT$152.62MCash & Cash Equivalents
NT$512.19MNet Debt
79.27%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Prince Pharmaceutical Co., Ltd. (ticker: 6935) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 210 employees.

The current price is 29.65 with a P/E ratio of -x and P/B of -x.

ROE is 12.34% and operating margin is 10.50%. Annual revenue is $1.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Prince Pharmaceutical Co., Ltd. (6935) Stock Forecast 2026 $29.65 — Price, Financials & Analyst Targets | Alpha Lenz